Please use this identifier to cite or link to this item:
https://islhd.intersearch.com.au/islhdjspui/handle/1/6294| Title: | Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma |
| ISLHD Author: | Parmar, Gurdeep |
| Authors: | Facon T;Dimopoulos MA;Leleu XP;Beksac M;Pour L;Hájek R;Liu Z;Minarik J;Moreau P;Romejko-Jarosinska J;Spicka I;Vorobyev VI;Besemer B;Ishida T;Janowski W;Kalayoglu-Besisik S;Parmar G;Robak P;Zamagni E;Goldschmidt H;Martin TG;Manier S;Mohty M;Oprea C;Brégeault MF;Macé S;Berthou C;Bregman D;Klippel Z;Orlowski RZ;IMROZ Study Group |
| Keywords: | Myeloma |
| Date Published: | 31-Oct-2024 |
| Citation: | N Engl J Med. 2024 Oct 31;391(17):1597-1609. doi: 10.1056/NEJMoa2400712. Epub 2024 Jun 3. |
| URI: | https://islhd.intersearch.com.au/islhdjspui/handle/1/6294 |
| DOI: | 10.1056/NEJMoa2400712 |
| Journal Title: | N Engl J Med |
| Appears in Collections: | Research publications from current and former ISLHD staff. |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.